Abstract
The most potent steroid in human prostatic carcinoma LNCaP cells, i.e., dihydrotestosterone (DHT), has a biphasic stimulatory effect on cell proliferation. At the maximal stimulatory concentration of 0.1 nm DHT, analysis of cell kinetic parameters shows a decrease of the G0-G1 fraction with a corresponding increase of the S and G2 + M fractions. In contrast, concentrations of 1 nm DHT or higher induce a return of cell proliferation to control levels, reflected by an increase in the G0-G1 fraction at the expense of the S and especially the G2 + M fractions. Continuous labeling for 144 h with the nucleotide analogue 5′-bromodeoxyuridine shows that the percentage of cycling LNCaP cells rises more than 90% after treatment with stimulatory concentrations of DHT, whereas in control cells as well as in cells treated with high concentrations of the androgen, this value remains below 50%. Although LNCaP cells do not contain detectable estrogen receptors, the new pure steroidal antiestrogen EM-139 not only reversed the stimulation of cell proliferation and cell kinetics induced by stimulatory doses of DHT but also inhibited basal cell proliferation.
Footnotes
-
↵1 This research was supported in part by the Medical Research Council of Canada (Group in Molecular Endocrinology), the Fonds de la Recherche en Santé du Québec, and Endorecherche.
-
↵2 Holder of a postdoctoral fellowship from the Medical Research Council of Canada.
-
↵3 Holder of a scholarship from the Medical Research Council of Canada.
-
↵4 To whom requests for reprints should be addressed, at Laboratory of Molecular Endocrinology, CHUL Research Center, 2705 Laurier Boulevard, Quebec, QC, G1V 4G2, Canada.
- Received March 22, 1991.
- Accepted July 15, 1991.
- ©1991 American Association for Cancer Research.